These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9260579)
21. The role of the MPL receptor in myeloproliferative disorders. Kaushansky K Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896 [TBL] [Abstract][Full Text] [Related]
22. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin. Souyri M Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168 [TBL] [Abstract][Full Text] [Related]
23. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines. Graf G; Dehmel U; Drexler HG Leuk Res; 1996 Oct; 20(10):831-8. PubMed ID: 8960108 [TBL] [Abstract][Full Text] [Related]
24. Phorbol ester PMA induces expression of the thrombopoietin receptor MPL in leukemia cells. Graf G; Zaborski M; Quentmeier H; Drexler HG Leuk Lymphoma; 1996 Dec; 24(1-2):149-57. PubMed ID: 9049971 [TBL] [Abstract][Full Text] [Related]
25. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315 [TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin activates the growth of megakaryoblasts in patients with chronic myeloproliferative disorders and myelodysplastic syndrome. Hashimoto S; Toba K; Fuse I; Watanabe K; Takahashi H; Abe T; Yano T; Koike T; Takahashi M; Aizawa Y Eur J Haematol; 2000 Apr; 64(4):225-30. PubMed ID: 10776693 [TBL] [Abstract][Full Text] [Related]
27. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412 [TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells. Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331 [TBL] [Abstract][Full Text] [Related]
29. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl. Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143 [TBL] [Abstract][Full Text] [Related]
30. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes. Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834 [TBL] [Abstract][Full Text] [Related]
31. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines. Drexler HG; Zaborski M; Quentmeier H Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695 [TBL] [Abstract][Full Text] [Related]
32. Role for C-MPL and its ligand thrombopoietin in early hematopoiesis. Katayama N; Itoh R; Kato T; Sugawara T; Mahmud N; Ohishi K; Masuya M; Aoki M; Minami N; Miyazaki H; Shiku H Leuk Lymphoma; 1997 Dec; 28(1-2):51-6. PubMed ID: 9498703 [TBL] [Abstract][Full Text] [Related]
33. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways. Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431 [TBL] [Abstract][Full Text] [Related]
35. Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy. Kaban K; Kantarjian H; Talpaz M; O'Brien S; Cortes J; Giles FJ; Pierce S; Albitar M Cancer; 2000 Feb; 88(3):570-6. PubMed ID: 10649249 [TBL] [Abstract][Full Text] [Related]
36. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. Morita H; Tahara T; Matsumoto A; Kato T; Miyazaki H; Ohashi H FEBS Lett; 1996 Oct; 395(2-3):228-34. PubMed ID: 8898102 [TBL] [Abstract][Full Text] [Related]
37. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells. Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641 [TBL] [Abstract][Full Text] [Related]
38. c-mpl, the thrombopoietin receptor. Vainchenker W; Methia N; Debili N; Titeux M; Wendling F Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519 [TBL] [Abstract][Full Text] [Related]
39. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377 [TBL] [Abstract][Full Text] [Related]
40. Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia. Motoji T; Takanashi M; Motomura S; Wang WH; Shiozaki H; Aoyama M; Mizoguchi H Br J Haematol; 1996 Sep; 94(3):513-6. PubMed ID: 8790152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]